• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

死亡或缓解:支气管肺发育不良中肺动脉高压的“自然史”。

Death or resolution: the "natural history" of pulmonary hypertension in bronchopulmonary dysplasia.

机构信息

Division of Neonatology - Department of Pediatrics - McGill University, Montreal Children's Hospital - McGill University Health Centre, Montreal, Canada.

Neonatal and Developmental Medicine, Stanford University School of Medicine - Lucile Packard Children's Hospital, Stanford, CA, USA.

出版信息

J Perinatol. 2019 Mar;39(3):415-425. doi: 10.1038/s41372-018-0303-8. Epub 2019 Jan 7.

DOI:10.1038/s41372-018-0303-8
PMID:30617286
Abstract

OBJECTIVES

The primary objective was to describe the early "natural history" of pulmonary hypertension (PH) in the premature population. The secondary objective was to describe factors associated with poor outcomes in the premature population with PH at 36 weeks post-menstrual age (PMA).

STUDY DESIGN

Retrospective chart review of patients followed at our institution from 2000 to 2017 with echocardiographic (ECHO) evidence of PH at 36 weeks PMA, and born ≤ 32 weeks estimated gestational age (GA). Cox regression was used for survival analysis.

RESULTS

Sixty-one patients with PH (26.5 ± 1.5 weeks at birth) were included. All PH patients had bronchopulmonary dysplasia (BPD), with 89% considered severe; 38% were small for gestational age. Necrotizing enterocolitis requiring surgery was common (25%). Use of post-natal steroids (HR 11.02, p = 0.01) and increased severity of PH (HR 1.05, p < 0.001) were associated with mortality. Pulmonary vein stenosis (PVS) was documented in 26% of the PH cohort, but not associated with increased mortality. ECHO estimation of pulmonary artery pressure (PAP) was available in 84%. PAP was higher in those who died (sPAP/sBP ratio 1.09 ± 27 vs 0.83 ± 20 %, p = 0.0002). At follow-up (mean 250 ± 186 weeks PMA), 72% of the PH cohort was alive. Most survivors (66%) had resolution of their PH on their most recent ECHO; 31% remained on PH therapy.

CONCLUSION

PH resolved in most survivors in this study population. Mortality in those with BPD-PH was associated with male sex, post-natal steroid use, and increased severity of PH, but not with PVS.

摘要

目的

主要目的是描述早产儿人群中肺动脉高压(PH)的早期“自然史”。次要目的是描述在 36 周胎龄(PMA)时具有 PH 的早产儿人群中与不良结局相关的因素。

研究设计

对 2000 年至 2017 年在我院就诊并在 36 周 PMA 时具有超声心动图(ECHO)证据的 PH 且出生胎龄(GA)≤32 周的患者进行回顾性图表审查。使用 Cox 回归进行生存分析。

结果

共有 61 例 PH 患者(出生时 26.5±1.5 周)入选。所有 PH 患者均患有支气管肺发育不良(BPD),其中 89%为重度;38%为小于胎龄儿。常见需要手术治疗的坏死性小肠结肠炎(25%)。使用产后类固醇(HR 11.02,p=0.01)和 PH 严重程度增加(HR 1.05,p<0.001)与死亡率相关。PH 队列中有 26%的患者记录到肺静脉狭窄(PVS),但与死亡率增加无关。84%的 PH 患者可进行 ECHO 估计肺动脉压(PAP)。死亡患者的 PAP 更高(sPAP/sBP 比值 1.09±27 对 0.83±20%,p=0.0002)。在随访(平均 36 周 PMA)时,PH 队列中有 72%的患者存活。在本研究人群中,大多数幸存者(66%)最近的 ECHO 显示 PH 已缓解;31%仍在接受 PH 治疗。

结论

在本研究人群中,大多数幸存者的 PH 得到缓解。BPD-PH 患者的死亡率与男性、产后类固醇使用和 PH 严重程度增加相关,但与 PVS 无关。

相似文献

1
Death or resolution: the "natural history" of pulmonary hypertension in bronchopulmonary dysplasia.死亡或缓解:支气管肺发育不良中肺动脉高压的“自然史”。
J Perinatol. 2019 Mar;39(3):415-425. doi: 10.1038/s41372-018-0303-8. Epub 2019 Jan 7.
2
Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants.早期肺动脉高压是极早产儿支气管肺发育不良相关晚期肺动脉高压的一个危险因素。
Sci Rep. 2021 May 27;11(1):11206. doi: 10.1038/s41598-021-90769-4.
3
Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.有患支气管肺发育不良风险的早产儿的早期肺血管疾病
Am J Respir Crit Care Med. 2015 Jan 1;191(1):87-95. doi: 10.1164/rccm.201409-1594OC.
4
Early cardiac function and death, severe bronchopulmonary dysplasia and pulmonary hypertension in extremely preterm infants.极早产儿的早期心功能与死亡、严重支气管肺发育不良和肺动脉高压。
Pediatr Res. 2024 Jan;95(1):293-301. doi: 10.1038/s41390-023-02817-6. Epub 2023 Sep 19.
5
Pulmonary vein stenosis of ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia, epidemiology, and survival from a multicenter cohort.患有肺动脉高压和支气管肺发育不良的早产低体重儿的肺静脉狭窄、流行病学及多中心队列研究的生存情况
Pediatr Pulmonol. 2017 Aug;52(8):1063-1070. doi: 10.1002/ppul.23679. Epub 2017 Feb 2.
6
Pulmonary Vein Stenosis in Neonates with Severe Bronchopulmonary Dysplasia.患有严重支气管肺发育不良的新生儿的肺静脉狭窄
Am J Perinatol. 2016 Jun;33(7):671-7. doi: 10.1055/s-0035-1571201. Epub 2016 Feb 10.
7
Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm.呼吸严重程度评分与极早产儿支气管肺发育不良相关肺动脉高压的关系。
J Perinatol. 2024 Feb;44(2):294-300. doi: 10.1038/s41372-023-01798-y. Epub 2023 Oct 18.
8
Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.支气管肺发育不良相关的肺动脉高压:来自胎盘病理学的线索
J Perinatol. 2017 Dec;37(12):1310-1314. doi: 10.1038/jp.2017.130. Epub 2017 Sep 7.
9
Pulmonary hypertension in a neonatologist-performed echocardiographic follow-up of bronchopulmonary dysplasia.新生儿科医生行超声心动图随访时发现肺动脉高压合并支气管肺发育不良。
Eur J Pediatr. 2021 Jun;180(6):1711-1720. doi: 10.1007/s00431-021-03954-y. Epub 2021 Jan 21.
10
Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia.超声心动图筛查对支气管肺发育不良早产儿出院时肺动脉高压的危险因素的评估。
Pediatr Cardiol. 2022 Dec;43(8):1743-1751. doi: 10.1007/s00246-022-02911-2. Epub 2022 Apr 29.

引用本文的文献

1
The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi-Prong Approach for a Heterogeneous Disease.间充质基质细胞在支气管肺发育不良治疗中的作用:针对一种异质性疾病的多管齐下方法
Compr Physiol. 2025 Aug;15(4):e70038. doi: 10.1002/cph4.70038.
2
Pulmonary vasodilator use in very preterm infants in United States children's hospitals.美国儿童医院中极早产儿使用肺血管扩张剂的情况。
J Perinatol. 2025 May 2. doi: 10.1038/s41372-025-02309-x.
3
Inhaled Nitric Oxide for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Systematic Review and Narrative Synthesis.
吸入一氧化氮治疗支气管肺发育不良相关肺动脉高压:一项系统评价与叙述性综合分析
Neonatology. 2025;122(4):467-476. doi: 10.1159/000545034. Epub 2025 Mar 3.
4
Digging deeper into necrotizing enterocolitis: bridging clinical, microbial, and molecular perspectives.深入探究坏死性小肠结肠炎:连接临床、微生物和分子层面的观点
Gut Microbes. 2025 Dec;17(1):2451071. doi: 10.1080/19490976.2025.2451071. Epub 2025 Jan 18.
5
Endothelial Cpt1a Inhibits Neonatal Hyperoxia-Induced Pulmonary Vascular Remodeling by Repressing Endothelial-Mesenchymal Transition.内皮细胞Cpt1a通过抑制内皮-间充质转化来抑制新生儿高氧诱导的肺血管重塑。
Adv Sci (Weinh). 2025 Mar;12(11):e2415824. doi: 10.1002/advs.202415824. Epub 2025 Jan 12.
6
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series).肺血管疾病的精准医学:未来已来(2023年格罗弗会议系列)
Pulm Circ. 2025 Jan 2;15(1):e70027. doi: 10.1002/pul2.70027. eCollection 2025 Jan.
7
Pulmonary vasodilator use in very preterm infants in United States children's hospitals.美国儿童医院中极早产儿使用肺血管扩张剂的情况。
Res Sq. 2024 Dec 5:rs.3.rs-5492163. doi: 10.21203/rs.3.rs-5492163/v1.
8
Persistent pulmonary hypertension in children after apparent resolution of ultrasound-defined pulmonary hypertension associated with bronchopulmonary dysplasia.儿童持续性肺动脉高压,尽管超声定义的与支气管肺发育不良相关的肺动脉高压已明显缓解。
Eur J Pediatr. 2024 Nov 19;184(1):26. doi: 10.1007/s00431-024-05843-6.
9
Home is where the right ventricle lives: bronchopulmonary dysplasia-associated pulmonary hypertension and home ventilation.家是右心室所在之处:支气管肺发育不良相关的肺动脉高压与家庭通气
Pediatr Res. 2025 Jan;97(1):31-32. doi: 10.1038/s41390-024-03550-4. Epub 2024 Sep 12.
10
Embracing the challenges of neonatal and paediatric pulmonary hypertension.拥抱新生儿和儿科肺动脉高压的挑战。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01345-2024. Print 2024 Oct.